6 | Dopamine (Intropin)FDA LinkGeneric
02/2016
-
07/2008 |
5 | Tacrine (Cognex)FDA Link
01/2020
-
07/2007 |
5 | Levodopa (L Dopa)FDA LinkGeneric
01/2020
-
07/2007 |
3 | Pharmaceutical PreparationsIBA
11/2014
-
07/2007 |
3 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2011
-
03/2009 |
3 | Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
03/2011
-
07/2007 |
2 | Cholinergic Agents (Cholinergics)IBA
11/2019
-
02/2016 |
2 | Neurotransmitter Agents (Neurotransmitter)IBA
11/2019
-
11/2014 |
2 | AMPA Receptors (AMPA Receptor)IBA
10/2015
-
12/2014 |
2 | 2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA
03/2011
-
07/2007 |
1 | sarizotanIBA
01/2020 |
1 | Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2020 |
1 | Acetylcholine (Acetylcholine Chloride)FDA Link
11/2019 |
1 | Antidepressive Agents (Antidepressants)IBA
03/2017 |
1 | Sirolimus (Rapamycin)FDA Link
02/2016 |
1 | AcetyltransferasesIBA
02/2016 |
1 | Therapeutic UsesIBA
02/2016 |
1 | RO5166017IBA
10/2015 |
1 | Trace amine-associated receptor 1IBA
10/2015 |
1 | Oxidopamine (6 Hydroxydopamine)IBA
10/2015 |
1 | AcidsIBA
12/2014 |
1 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2014 |
1 | N-Methylaspartate (NMDA)IBA
12/2014 |
1 | Messenger RNA (mRNA)IBA
12/2014 |
1 | Transcription Factors (Transcription Factor)IBA
02/2013 |
1 | N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2010 |
1 | 8-ethoxy- 9-ethyladenineIBA
03/2010 |
1 | Adenosine (Adenocard)FDA LinkGeneric
12/2009 |
1 | Neuroprotective AgentsIBA
12/2009 |
1 | 5- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
12/2009 |
1 | Probenecid (Benemid)FDA LinkGeneric
03/2009 |
1 | PPAR gammaIBA
03/2009 |
1 | Rosiglitazone (Avandia)FDA Link
03/2009 |